Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Raymond James

Rocket Lab Stock Just Scored a New Bullish Rating

Rocket Lab stock gains on a bullish Raymond James research note. Here’s why analyst Brian Gesuale recommends owning RKLB shares.

Barchart

Nvidia Can Clearly Afford a Bigger Dividend. Why Its Payout Hasn’t Grown.

Nvidia left its quarterly dividend unchanged at $0.25 after reporting Q2 revenue of $96.2 billion, even though the company clearly has the cash to pay more.

Barchart

A Major $12.9 Billion Catalyst Is Brewing for Nvidia Stock

Nvidia’s reported $12.9 billion acquisition of Hugging Face could be a major catalyst, helping it expand in the fast-growing open-source model and developer ecosystem.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

AMD Stock Alert: Raymond James Sees $201B Revenue Opportunity by 2030

AMD upgraded by Raymond James citing agentic AI demand growth.

Barchart

A $6 Billion Reason to Buy Nvidia Stock Now

Nvidia’s $6 billion Poolside deal could strengthen its AI software ambitions and give investors another reason to bet on NVDA’s long-term dominance beyond GPUs.

Barchart

Applied Optoelectronics Has a Rare Problem Thanks to a Possible U.S. Ban on China

Applied Optoelectronics already has more AI-optics demand than it can fulfill, and a potential U.S. ban on Chinese suppliers could make its race to expand capacity even more important.

Barchart

AeroVironment Just Scored a New Army Contract. What It Means for AVAV Stock.

Investors will pay close attention to the effects of the new U.S. Army contract worth $117.30 million for AeroVironment stock.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Oil Is Trapped At Hormuz: These 3 Refiner Stocks Are Cashing In

American refiners are minting money. The margin they earn turning crude into fuel has just surged to a record high as hostilities in the Strait of Hormuz flare up once again. The stocks tied to that trade are now leading the S&P 500 in July.

Benzinga

SpaceX Stock Falls To Record Low, But One Analyst Sees it Hitting $800

Space Exploration Technologies (NASDAQ:SPCX) stock has plunged to a record low, wiping out more than $1 trillion in market value as the enthusiasm that fueled its post-IPO rally faded.

Benzinga

SpaceX stock falls back to earth shortly after Wall Street analysts release florid targets: 'Paving the superhighway to the stars'

A wave of wildly bullish price targets from Wall Street's SpaceX underwriters arrived just before the stock fell—raising questions about how much analysts really know.

Fortune

Why Investors Pay Premiums for Some Private Credit Lenders — And Deep Discounts for Others

As private credit has grown into a roughly $1.8 trillion asset class, one question has become increasingly difficult for investors to answer: which lenders are actually outperforming, and which are simply benefiting from an opaque market?

Benzinga

Dollar Tree’s Turnaround Is Starting to Take Root

Dollar Tree authorized a $2.5 billion buyback and posted 120 bps of gross margin expansion, prompting upgrades from Raymond James and Goldman Sachs despite lingering weak foot traffic.

MarketBeat

SpaceX Scored a New Street-High Price Target of $800. What Comes Next for SPCX Stock.

Raymond James says SpaceX stock could hit as much as $800. Here’s what it would take for SPCX shares to hit the firm’s price target.

Barchart

Why Chapter 11 Might Be the Best Move for JetBlue Stock in 2026

JetBlue faces mounting financial strain as Raymond James flags restructuring, despite solid liquidity.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

2 Analysts Just Upgraded Dollar Tree Stock. Here's Why.

Dollar Tree stock inches higher as Raymond James and Goldman Sachs upgrade the discount retailer. Here’s why each of those firms turned more bullish on DLTR shares today.

Barchart

Why 1 Veteran Analyst Doubled Her Micron Stock Price Target for 2026

Wall Street is turning increasingly bullish on Micron after record earnings, strong guidance, and growing AI data-center demand.

The Economic Times

MU stock price today hits new record above $1,000 as Micron crosses $1 trillion market cap: What's driving the rally and what are analysts' price targets?

Micron (MU) stock price target: Micron Technology's stock surged past $1,000, driven by robust demand for AI infrastructure and its key role in supplying high-bandwidth memory (HBM). Analysts are raising price targets, with some projecting significant long-term growth, though forecasts remain divided on the sustainability of the AI boom.

Barchart

What Are Wall Street Analysts' Target Price for Raymond James Stock?

Although Raymond James has lagged the broader market over the past year, Wall Street analysts remain moderately optimistic about the company’s long-term outlook.

Get all your
news in one place.

100's of premium titles.
One news app.

Kiplinger

Kiplinger Readers' Choice Awards 2026: Best Brokers

The Kiplinger Readers’ Choice Awards celebrate the best products and services in personal finance.

Barchart

Raymond James Is Betting Okta Stock Can Gain from Here. Should You Buy Shares Now?

Okta has gone from “SaaS‑pocalypse” casualty to profitable cash generator, and with identity security sitting at the center of how enterprises manage both humans and AI agents, an upside gap to Street targets makes the risk‑reward look attractive.

Barchart

Jazz Pharmaceuticals Stock, a Barchart Favorite, Trends Higher as Trump Renews Cannabis Hopes. Should You Buy JAZZ Here?

Jazz Pharmaceuticals stock pops as President Trump signals renewed urgency to reclassify cannabis as Schedule III drug. Technicals signal further upside ahead in JAZZ shares.

Barchart

Dear UnitedHealth Stock Fans, Mark Your Calendars for April 21

UNH stock is facing very tough challenges as the company gears up to report first-quarter earnings.

Barchart

UnitedHealth Stock Is Down Nearly 50% over the Past Year, but This 1 Analyst Is Still Betting on UNH to Outperform

Beaten-down UnitedHealth stock has received an “Outperform” rating from Raymond James analysts.

Barchart

Raymond James Financial Stock: Is RJF Underperforming the Financial Sector?

While Raymond James Financial has underperformed the broader financial sector lately, analysts continue to hold a moderately optimistic view of the stock.

Barchart

Raymond James Stock: Is Wall Street Bullish or Bearish?

Raymond James has underperformed the broader market over the past year, yet analysts remain moderately bullish about the stock’s prospects.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.